Real-time QCM-D immunoassay through oriented antibody immobilization using cross-linked hydrogel biointerfaces

Shawn D Carrigan1, George Scott, Maryam Tabrizian

  • 1Department of Biomedical Engineering, McGill University, 3775 University Street, Duff Medical Building, Room 316, Montreal, Quebec, Canada.

Insights

We developed new antibody immobilization platforms for rapid sepsis biomarker detection using QCM-D. The optimized assay achieves a 25 ng/mL detection limit with high repeatability, minimizing non-specific binding.

Area of Science:

  • Biomaterials Science
  • Biosensor Technology
  • Analytical Chemistry

Background:

  • Sepsis biomarker detection is critical for timely clinical intervention.
  • Quartz Crystal Microbalance with Dissipation monitoring (QCM-D) offers a sensitive and affordable platform for immunoassays.
  • Developing efficient antibody immobilization strategies is key to enhancing biosensor performance.

Purpose of the Study:

  • To develop and optimize pre-cross-linked and in situ cross-linked polyethyleneimine-carboxymethylcellulose platforms for antibody immobilization.
  • To establish a real-time QCM-D immunoassay for sepsis-related biomarkers with enhanced sensitivity and robustness.
  • To investigate methods for improving assay performance, including oriented antibody immobilization and signal amplification.

Main Methods:

  • Fabrication of pre-cross-linked and in situ cross-linked polymer platforms using polyethyleneimine and carboxymethylcellulose.
  • Development of a QCM-D immunoassay using recombinant human interleukin-1 receptor antagonist (rhIL-1ra) as a model sepsis biomarker.
  • Optimization of antibody immobilization using Protein A, Protein G, and anti-IgG Fc ligands on higher-frequency QCM-D crystals.
  • Implementation of secondary antibody amplification and assessment of assay repeatability and nonspecific adsorption using human serum albumin.

Main Results:

  • Achieved ultrafast biointerface deposition through polysaccharide cross-linking.
  • Optimized assay with Protein A oriented immobilization and secondary antibodies yielded a detection limit of 25 ng/mL on 5 MHz crystals.
  • Demonstrated robust assay repeatability with no loss in antigen detection over 20 cycles of a 10-minute assay.
  • Confirmed minimal and negligible nonspecific adsorption of human serum albumin on the developed platforms.

Conclusions:

  • The developed polyethyleneimine-carboxymethylcellulose platforms enable rapid and sensitive QCM-D immunoassay of sepsis biomarkers.
  • Oriented antibody immobilization and secondary antibody amplification significantly enhance assay performance.
  • The optimized QCM-D immunoassay exhibits excellent sensitivity, repeatability, and low nonspecific binding, suitable for real-time sepsis diagnostics.